The preferred file format is Word (.doc or .docx). Acceptable formats
for pictures, photographs and figures are .jpg, and .tif. Please do not
send pdf files. Send 2 hard copies of the manuscript and its electronic
version (e-mail, CD-ROM). The disc must be marked with names of the authors,
and the format and word processor program used. In the electronic version,
separate files should be used for the text, figures, and tables.
The Manuscript should be prepared in double-spaced 12-pt font, preferably
Arial and Times New Roman, on single-column, single sided, providing 25
mm margins. Number the pages of the manuscript successively, beginning
with the title page as page 1. Each following segment of the manuscript
(e.g. Introduction, Methods, Results, etc.) has to start on the next separated
|TITLE PAGE. The title
page should include a concise but informative title, the authors'
full names, the department/institution and each author's address
with the symbol to link authors and their addresses. Also,
the title page must include the name, address, fax and telephone
numbers, e-mail of the author to whom correspondence should
be addressed, details of source of support in the form grant,
equipment and drugs, word counts (for the abstract and the
text without the abstract), the number of figures and tables.
ABSTRACT. The abstract starts on the second page. Original
articles must contain a structured abstract of up to 300 words,
titled Background, Methods, Results, and Conclusion. Structured
abstracts are not required in review articles, case reports,
and other contributions.
KEY WORDS. Include 3 to 6 key words below the abstract, taken
from the Medical Subject Headings (MeSH).
COVERING LETTER. An example of the covering letter: "Those
undersigned claim that the manuscript has not been published
elsewhere as a whole, or partly. We agree with the content
of the manuscript and approve its publication in the Archive
of Oncology. Researching has been approved by the institutional
Ethics Committee. There are no financial problems that might
lead to a conflict of interest."
As for the previous publications, please provide that no substantial
part of the manuscript may have been or may be published elsewhere.
This restriction does not apply to abstracts or press reports
published in connection with scientific meetings. For advice
on previous or simultaneous publication, contact the Editorial
CONFLICT OF INTEREST. Declaration of Competing Interest Form
can be downloaded from the website (http://www.onk.ns.ac.rs/archive/Declaration.pdf):
Proofs in PDF format will be sent to the corresponding author via e-mail
and should be returned within 48 hours of receipt. Sending of corrected
proof by fax should be avoided. Corrections should be restricted to typewriting
errors as any substantial changes other than these may be charged to the
author. The responsibility of defeating errors is with the author.
PROTECTION OF RESEARCH HUMAN AND ANIMAL SUBJECTS
When reporting experiments on human subjects, indicate whether the procedures
applied were in accordance with the ethical standards of the responsible
committee on human experimentation (institutional or regional) or with
the Helsinki Declaration (1964, amended in 1975, 1983, 1989, 1996, and
revised in 2000) of the World Medical Association. Do not use patients'
names, initials, or hospital numbers, especially in any illustrative material.
When reporting experiments on animals, indicate whether the institution's
or the National Research Council's guide for, or any national law on the
care and use of laboratory animals was followed.
Articles should be written according to the unique rules for manuscripts
published in biomedical journals, published by the International Committee
of Medical Journal Editors (Vancouver style) in www.icmje.org
(Serbian translation taken from the Serbian Archive, special issue 1999;127:88).
Research articles are scientific reports of the results
of original clinical or experimental research. The text
is limited to 3,000 words, with structured abstract up to
300 words, maximum of 5 tables and figures (total), and
up to 50 references.
All randomized controlled trials submitted for publication
in the Archive of Oncology should include a completed Consolidated
Standards of Reporting Trials (CONSORT) flow chart. Please
refer to the CONSORT statement website at: http://www.consort-statement.org/
for more information.
Clinical trials should be registered in accordance with
the criteria outlined by the International Committee of
Medical Journal Editors, including the June 2007 update.
META-ANALYSES. Meta-analyses are reviews of randomized trials.
Authors are encouraged to submit QUOROM Statement (Quality
of Reporting of Meta-analyses) which consists of a checklist
and flow diagram) or the MOOSE (Meta-analysis of Observational
Studies in Epidemiology). See: http://www.consort-statement.org.
REVIEW ARTICLES. The editor generally solicits reviews.
These manuscripts summarize the state-of-the-art in a particular
field. They should contain no more than 4,000 words, up
to 75 references, maximum of 5 tables and figures (total),
and a non-structured abstract of up to 300 words.
CASE REPORTS. These articles should contain no more than
2,000 words, excluding the references (up to 25), a non-structured
abstract of up to 200 words, and up to 3 figures. There
should be no more than five authors. A written consent for
publication must be obtained from the patient.
may express opinions on any subject relevant to the journal's
aims and scope, or may comment the significance of articles
in the same issue of the journal. The editors usually commission
editorials, but we are happy to consider unsolicited submissions
also. Editorials should contain about 1,200 words but its
length may be negotiated at the time of invitation, and
up to 15 references. An abstract is not required.
SPECIAL ARTICLE. Articles on clinical oncology, experimental
oncology, cancer epidemiology and prevention, and social
and ethical aspects of cancer. Recommended: an unstructured
abstract of 200 words, and no more than 3,000 words of the
IMAGING IN CLINICAL ONCOLOGY are classic images of common
medical conditions. Visual images are important part of
much of what we do and learn in medicine. This feature is
intended to capture the sense of visual discovery and variety
that physicians experience. Imaging in clinical oncology
are not intended as a vehicle for case reports.
LETTERS TO THE EDITOR. Letters are welcome and will be published
if appropriate. They should be no longer than 500 words
and a maximum of 10 references and 1 figure or table.
COMMENTARY. These manuscripts describe an important topic
in oncology which is not linked to a specific article. Recommended
lenght: up to 2,000 words and 1 table or figure, and no
more than 25 references.
BOOK REVIEWS. Book reviews are solicited by the book review
editor. Unsolicited book reviews are welcome and contain
up to 500 words.
Any substantial error in a published paper will be corrected
as soon as possible.
SUPPLEMENTS / PROCEEDINGS OF SYMPOSIA
Papers from meetings can be published as an extended supplement
to the journal, providing for the full expenses of such
supplements. Supplements are accepted for publication on
the discretion of the Editor-in-Chief if they are to adhere
to editorial policy and acceptance standards, and be subject
to peer review.
|TABLES. Each table
with a brief title should be typed double-spaced on a separate
sheet of paper at the end of your file. Number tables consecutively
(with Arabic numerals) in the order of their first citation
in the text. Give each column a short or abbreviated heading.
Place explanations in legends of all nonstandard abbreviations
used in the table (up to 40 words).
For units and measurements see the paragraph below. Do not
use internal horizontal and vertical rules. Always separate
the individual columns using tabulators, not a space bar,
i.e. tables must be in text format.
FIGURES. Line drawings, diagrams and halftone illustrations
(photographs, photomicrographs, etc.) should be designated
as figures. They should also be listed on a separate sheet
and numbered consecutively with Arabic numerals according
to the order in which they have been first cited in the text.
Figures should be professionally drawn (not simply typewritten)
and photographed. Each figure should be labeled on its back
indicating the number of the figure, last name and the first
letter of the author, and the topside of the figure.
Photographs should be supplied in 2 copies. Photomicrographs
must have internal scale markers, and symbols, arrows or letters
should contrast with the background. Photographs of patients
must conceal their identity unless patients' written consent
for publishing the photograph is obtained. If you borrow or
use already published photographs, please submit a written
permission for reproduction. Permission is not required for
the documents in the public domain.
Figures will not be returned unless requested. Captions and
detailed explanations of the figures should be given in the
legends. If symbols, arrows, numbers, or letters are used
to identify parts of the figure, identify and explain each
one clearly in the legend.
Submit the text and tables of each manuscript as a single
file, but place all figures, charts etc., in separate files.
Allowed graphic formats are EPS, JPG, and TIF. The figures
should be either 8.5 cm or 18.0 cm in size, their minimal
resolution 300 dpi. Please send original photographs, do not
ACKNOWLEDGEMENTS. Acknowledgments should precede the reference
list, specifying general support by a department chairman,
acknowledgements of technical help and of financial and material
PERMISSIONS. The author must obtain a permission to reproduce
figures, tables, and the text of the previously published
material, even if that is the author's own work. A written
permission must be obtained from the original copyright holder
(generally the publisher, not the author or editor) of the
journal or book concerned. An appropriate credit should be
included in the reference list. A written permission must
be obtained from the author of any unpublished material cited
from other institutions and should accompany the manuscript.
Sending proofs by fax should be avoided.
FOOTNOTES. Footnotes to the title page and the text are to
be designated consecutively with superscript Arabic numerals.
ADDENDA. Data acquired after acceptance of the paper, by the
authors themselves or by others, cannot be added to the text.
An addendum may be included at the proof stage as a "note
added in proof", preceding the reference section. However,
such addenda are subject to approval by the Editor-in-Chief
and could result by delay of publication. Addenda should be
kept extremely brief.
UNITS OF MEASUREMENT. Authors should use the SI units. Authors
should express all measurements in conventional units, with
Systéme International (SI) units (http://www.bipm.org/en/si)
given in parentheses throughout the text, or authors may consult
Units, symbols and abbreviations: a guide for biological and
medical editors and authors, 5th ed., London: Royal Society
of Medicine, 1994, or Trpinac P, Savin S, Medakoviæ
B. Internacionalni sistem mernih jedinica (IS) u medicini
i farmaciji, Beograd-Zagreb: Praxis Medica, Medicinska knjiga,
1979. Also, see http://clincancerres.aacrjournals.org/misc/ifora.shtml.
Figures and tables should use conventional units, with conversion
factors given in legends or footnotes.
ABBREVIATIONS AND SYMBOLS. The Archive of Oncology accepts
Standard Journal of Biological Chemistry Abbreviations. Generally,
avoid abbreviations in the title. In the text, whenever possible,
use standard abbreviations. However, if non-standard abbreviations
are used, the full term of which an abbreviation stands for
should precede its first use in the text. A list of abbreviations
and acronyms accepted for use in the Archive of Oncology can
be downloaded from the following URL: http://www.aacr.org/pdf_files/Accepted_Abbreviations_Acronyms_2004.pdf.
DRUG NAMES. Use generic names for drugs. Commercial names
may be included in parenthesis at first mention in the text.
Authors may consult http://www.alims.gov.rs.
Complicated drug names or regimens may be abbreviated, with
the abbreviation in parenthesis after first mention.
GENE NOMENCLATURE. The Archive of Oncology does not italicize
the symbols designating genes, alleles, or loc. All Human
Gene Mapping designations for human genes should be capitalized.
BIOCHEMICAL NOMENCLATURE. For biochemical nomenclature, authors
may consult www.iubmb.unibe.ch.
MICROARRAY AND PROTEOMIC DATA. The Archive of Oncology requires
that the manuscripts describing microarray data are prepared
to supply peer reviewers with the data in a format that conforms
to the Minimum Information About a Microarray Gene Experiment
(MIAME) guidelines of the Microarray Gene Expression Data
society (MGED) (http://www.mged.org/Workgroups/MIAME/miame.html).
Authors are also encouraged to deposit the data with either
the GEO (http://www.ncbi.nlm.nih.gov/projects/geo)
or Array Express (http://www.ebi.ac.uk)
PROTEOMIC ANALYSES. See Biomolecular Interaction Network Database
SEQUENCE INFORMATION. The authors of a manuscript containing
new nucleotide and/or aminoacid sequences are asked to deposit
the sequence information with the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/submit.html),
or to either the European Molecular Biology Laboratory (EMBL)
or the DNA Databank of Japan (http://www.ddbj.nig.ac.jp/sub-e.html).
GUIDELINES FOR STEM CELL RESEARCH. Research with embryonic
stem cells should adhere to the National Academies' Guidelines
for Human Embryonic Stem Cell Research, as published in the
National Academies Press.
TUMORS. Authors are advised to use the TNM staging system
approved by the International Union Against Cancer and the
American Joint Committee on Cancer.
STATISTICAL GUIDELINES. The methods of statistical analysis
describe sufficient details on the analyses carried out to
enable reader to reproduce the analysis if the data were available.
Authors should identify and cite all computer programs or
statistical packages used in the analysis, and measures of
precision and uncertainty for all statistical estimates. The
word "significant" should be used only for statistically
significant results. A p-value or confidence interval (CI)
or other measures should be cited in the text for any statistically
significant finding reported. Outcome variables should be
given as estimates, with 95% confidence intervals rather than
standard deviations or standard errors.
The statistical analysis may be performed using the regression
analysis, adjust/trends, and explanations for insufficient
data. For clinical trials, it is necessary to report: important
study dates, sample size, interim analyses, compliance to
treatments, patient accounting, and characteristics, follow-up,
toxicity, and negative studies.
Bailar JC III, Mosteller F. Guidelines for statistical reporting
in articles for medical journals. Amplifications and explanations.
Ann Interna Med. 1988;108:266-73.
Altman DG. Statistic in medical journals: some recent trends.
Statistic Med. 2000;19:3275-89.
Moher D, Schultz KF, Altman DF, CONSORT Group. The CONSORT
statement: revised recommendations for improving the quality
of reports of parallel-group randomized trials. Clin Oral
Cummings P, Rivara FP. Reporting Statistical Information in
Medical Journal Articles Arch Pediatr Adolesc Med. 2003;157:321-4
Hadivukoviĉ S. Statistika. 3rd ed. Beograd: Privredni
REFERENCES. The Archive of Oncology reference style follows
the Uniform Requirements for Manuscripts Submitted to Biomedical
Authors should consult the List of Journals Indexed for MEDLINE
for standard abbreviations of journals (http://www.nlm.nih.gov/tsd/serials/lji.html).
Authors are responsible for accuracy of the literature data.
References should be listed in a separate section immediately
following the text. Only references important for the study
should be cited. Number references in the order of their first
mention in the text. Cite only the number assigned to the
reference, not the author. Try to avoid using abstracts as
references, but if so, after the titles note (abstr.). The
abstract cited should not be more than two years old.
of correct forms of references (for details see: http://www.nlm.nih.gov/bsd/uniform_requirements.html):
The first 6 authors are listed; thereafter add et al.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation
in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.
As an option, if a journal carries continuous pagination throughout
a volume (as many medical journals do) the month and issue
number may be omitted.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation
in HIV-infected patients. N Engl J Med. 2002;347:284-7.
More than six authors:
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding
JK, et al. Regulation of interstitial excitatory amino acid
concentrations after cortical contusion injury. Brain Res.
Optional addition of a database's unique identifier for the
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation
in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.
PubMed PMID: 12140307.
If the journal has a continuous page numbering, you may omit
the issue number, but if it is not the case, add the month
and date between the year of publication and the volume number.
Books and chapter citations
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical
microbiology. 4th ed. St. Louis: Mosby; 2002.
Editor(s), compiler(s) as author
Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative
obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
Author(s) and editor(s)
Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed.
Wieczorek RR, editor. White Plains (NY): March of Dimes Education
Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations
in human solid tumors. In: Vogelstein B, Kinzler KW, editors.
The genetic basis of human cancer. New York: McGraw-Hill;
2002. p. 93-113.
Dissertations and thesis
Bogdanoviĉ-Stojanoviĉ D. Magnetic resonance mammography in
comparison to other radiological methods for differentiating
lesions in breast saving surgeries [dissertation]. Novi Sad,
Serbia: University of Novi Sad; 2007.
References to information on the Internet
References to information available on the Internet are not
considered legitimate references because they are not permanent
and generally are not peer-reviewed. If the authors feel that
such information would be valuable to the readers, the URL
should be cited in a footnote.
Articles in journals:
Abood S. Quality improvement initiative in nursing homes:
the ANA acts in an advisory role. Am J Nurs [Internet]. 2002
Jun [cited 2002 Aug 12];102(6):[about 1 p.]. Available from:
Notice: Only first words of the article title and words that
normally begin with a capital letter are capitalized.
In press / Forthcoming
Note: NLM prefers "Forthcoming" rather than "In
press" because not all items will be printed.
Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature
of balancing selection in Arabidopsis. Proc Natl Acad Sci
U S A. Forthcoming 2002.
Papers in preparation or submitted for publication, unpublished
data, and personal communications should be cited in a footnote,
not in the reference section. The names of all authors should
be given, along with manuscript titles if possible. Permission
must be obtained from persons cited in a personal communication.
OBJECT IDENTIFIER. The Archive of Oncology assigns a unique digital
object identifier (DOI) to every article it publishes. The DOI initiative
is an international effort for electronic content identification and is
guided by the International DOI Foundation, composed primarily of academic
publishers and societies. The DOI appears on the title page of the article.
The DOI should be cited in a reference as follows:
Article with a Digital Object Identifier (DOI):
Zhang M, Holman CD, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity
and repeat admission to hospital for adverse drug reactions in older adults:
retrospective cohort study. BMJ. 2009 Jan 7;338:a2752. doi: 10.1136/bmj.a2752.
PubMed PMID: 19129307; PubMed Central PMCID: PMC2615549.
All the material published in the Archive of Oncology represents the
opinions of the authors and does not reflect the opinions of the Oncology
Institute of Vojvodina, the editors, or the institutions with which
the authors are affiliated.
Authors submitting manuscripts to the Archive of Oncology do so with
the understanding that if their manuscript is accepted, the copyright
in the article, including the right to reproduce the article in all
forms and media, shall be assigned exclusively to the publisher (The
Oncology Institute of Vojvodina), and that the corresponding author
and all coauthors will be required to sign and submit a copyright transfer
at the time of submission of the revised manuscript. The Archive Oncology
authors retain a number of the nonexclusive rights to their published
The copyright transfer agreement can be downloaded from www.onk.na.ac.rs/Archive.
All requests to reproduce or make available anything in the journal
as a whole or in its selected part, in electronic or in any other form,
should be sent to:
Archive of Oncology
Oncology Institute of Vojvodina
Put doktora Goldmana 4, 21204 Sremska Kamenica, Serbia,
Phone: +381 21 480 5577
Fax: +381 21 6613 741
Manuscripts should be submitted to the following address: The Oncology
Institute of Vojvodina, ARCHIVE OF ONCOLOGY, Attn.: Dr. Gordana Bogdanoviĉ,
Editor-in-Chief, Put doktora Goldmana 4, 21204 Sremska Kamenica, Serbia,
Publishing of papers in the Archive of Oncology is free of charge